Overweight or Obese
11
3
4
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
Innovative Functional Product for Overweight and Obesity
A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function
Pistachio Snacking and Metabolic Flexibility
Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)
A Study of BGM0504 in Overweight or Obese Participants
Phase II Study of THDBH120 Injection in Overweight or Obese Subjects
A Trial With EMP16 in Preparation for Late Phase Studies
A Study to Evaluate MWN109 Injection in Healthy Subjects
Dose-Response to Exercise in Women Aged 45-75 Years (DREW)
Weight Management in Mothers and Adult Daughters